135 related articles for article (PubMed ID: 37872057)
21. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
22. Corrigendum to "Emerging roles of Sirtuins in alleviating alcoholic liver disease: A comprehensive review" [Int. Immunopharmacol. 108 (2022) 108712].
Zhao X; Xue X; Wang C; Wang J; Peng C; Li Y
Int Immunopharmacol; 2023 Jun; 119():110248. PubMed ID: 37160407
[No Abstract] [Full Text] [Related]
23. Corrigendum to "Epigallocatechin gallate potentially abrogates fluoride induced lung oxidative stress, inflammation via Nrf2/Keap1 signaling pathway in rats: An in-vivo and in-silico study" [Int. Immunopharmacol. 39 (2016) 128-139].
Shanmugam T; Selvaraj M; Poomalai S
Int Immunopharmacol; 2020 Mar; 80():106203. PubMed ID: 31983588
[No Abstract] [Full Text] [Related]
24. Corrigendum to "Alpha-Mangostin suppresses interleukin-1β-induced apoptosis in rat chondrocytes by inhibiting the NF-κB signaling pathway and delays the progression of osteoarthritis in a rat model" [Int. Immunopharmacol. 52 (2017) 156-162].
Pan T; Chen R; Wu D; Cai N; Shi X; Li B; Pan J
Int Immunopharmacol; 2018 Dec; 65():559-560. PubMed ID: 30412853
[No Abstract] [Full Text] [Related]
25. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74).
Cain SA; Monk PN
J Biol Chem; 2002 Mar; 277(9):7165-9. PubMed ID: 11773063
[TBL] [Abstract][Full Text] [Related]
26. Corrigendum to "Berberine regulates PADI4-related macrophage function to prevent lung cancer" [Int. Immunopharmacol. 110 (2022) 108965].
Gu W; Zhang M; Gao F; Niu Y; Sun L; Xia H; Li W; Zhang Y; Guo Z; Du G
Int Immunopharmacol; 2023 Jul; 120():110366. PubMed ID: 37258402
[No Abstract] [Full Text] [Related]
27. Corrigendum to "4-Hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice" [Int. Immunopharmacol. 83 (2020) 106445].
Wang H; Wei X; Wei X; Sun X; Huang X; Liang Y; Xu W; Zhu X; Lin X; Lin J
Int Immunopharmacol; 2020 Sep; 86():106722. PubMed ID: 32593975
[No Abstract] [Full Text] [Related]
28. Corrigendum to "Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function" [Int. Immunopharmacol. (2015) 423-432].
Sun J; Shen X; Dong J; Zhao J; Zuo L; Wang H; Li Y; Zhu W; Gong J; Li J
Int Immunopharmacol; 2016 Jun; 35():341. PubMed ID: 27130814
[No Abstract] [Full Text] [Related]
29. Corrigendum to "Gypsophila elegans isoorientin-2″-O-α-L-arabinopyranosyl ameliorates porcine serum-induced immune liver fibrosis by inhibiting NF-κB signaling pathway and suppressing HSC activation" [Int. Immunopharmacol. 54 (2018) 60-67].
Bai F; Huang Q; Wei J; Lv S; Chen Y; Liang C; Wei L; Lu Z; Lin X
Int Immunopharmacol; 2023 Sep; 122():110697. PubMed ID: 37500383
[No Abstract] [Full Text] [Related]
30. New concepts on the therapeutic control of complement anaphylatoxin receptors.
Hawksworth OA; Li XX; Coulthard LG; Wolvetang EJ; Woodruff TM
Mol Immunol; 2017 Sep; 89():36-43. PubMed ID: 28576324
[TBL] [Abstract][Full Text] [Related]
31. Corrigendum to "The effectiveness of blood routine parameters and some biomarkers as a potential diagnostic tool in the diagnosis and prognosis of Covid-19 disease" [Int. Immunopharmacol. 98 (2021) 107838].
Huyut MT; İlkbahar F
Int Immunopharmacol; 2023 Oct; 123():110823. PubMed ID: 37661504
[No Abstract] [Full Text] [Related]
32. Corrigendum to "Antcin A alleviates pyroptosis and inflammatory response in Kupffercells of non-alcoholic fatty liver disease by targeting NLRP3" [Int. Immunopharmacol. 100 (2021) 108126].
Ruan S; Han C; Sheng Y; Wang J; Zhou X; Guan Q; Li W; Zhang C; Yang Y
Int Immunopharmacol; 2022 Mar; 104():108485. PubMed ID: 34955407
[No Abstract] [Full Text] [Related]
33. C5L2: a controversial receptor of complement anaphylatoxin, C5a.
Li R; Coulthard LG; Wu MC; Taylor SM; Woodruff TM
FASEB J; 2013 Mar; 27(3):855-64. PubMed ID: 23239822
[TBL] [Abstract][Full Text] [Related]
34. Corrigendum to "Curcumin attenuates sepsis-induced acute organ dysfunction by preventing inflammation and enhancing the suppressive function of Tregs" [Int. Immunopharmacol. 61 (2018) 1-7].
Chen L; Lu Y; Zhao L; Hu L; Qiu Q; Zhang Z; Li M; Hong G; Wu B; Zhao G; Lu Z
Int Immunopharmacol; 2024 Jun; ():112471. PubMed ID: 38879417
[No Abstract] [Full Text] [Related]
35. Differential effects of anaphylatoxin C5a on antigen presenting cells, roles for C5aR1 and C5aR2.
Zaal A; van Ham SM; Ten Brinke A
Immunol Lett; 2019 May; 209():45-52. PubMed ID: 30959077
[TBL] [Abstract][Full Text] [Related]
36. Corrigendum to "Ac-YVAD-cmk improves neurological function by inhibiting caspase-1-mediated inflammatory response in the intracerebral hemorrhage of rats" [Int. Immunopharmacol. 75 (2019) 105771].
Liang H; Sun Y; Gao A; Zhang N; Jia Y; Yang S; Na M; Liu H; Cheng X; Fang X; Ma W; Zhang X; Wang F
Int Immunopharmacol; 2023 Jun; 119():110283. PubMed ID: 37179200
[No Abstract] [Full Text] [Related]
37. Corrigendum to "Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-κB" [Int. Immunopharmacol. 101(Part B) (2021) 108290].
Zhu Y; Ruan S; Shen H; Guan Q; Zhai L; Yang Y
Int Immunopharmacol; 2023 Jun; 119():110302. PubMed ID: 37193623
[No Abstract] [Full Text] [Related]
38. Corrigendum to "Pathogenesis of Concanavalin A induced autoimmune hepatitis in mice" [Int. Immunopharmacol. 102 (2022) 108411].
Hao J; Sun W; Xu H
Int Immunopharmacol; 2022 Mar; 104():108550. PubMed ID: 35067473
[No Abstract] [Full Text] [Related]
39. Corrigendum to "IDO1: An important immunotherapy target in cancer treatment" [Int. Immunopharmacol. 47 (2017) 70-77].
Li F; Zhang R; Li S; Liu J
Int Immunopharmacol; 2017 Aug; 49():231. PubMed ID: 28457914
[No Abstract] [Full Text] [Related]
40. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]